DK1068328T3 - Behandling og diagnose af stafylokokinfektioner - Google Patents

Behandling og diagnose af stafylokokinfektioner

Info

Publication number
DK1068328T3
DK1068328T3 DK99913444T DK99913444T DK1068328T3 DK 1068328 T3 DK1068328 T3 DK 1068328T3 DK 99913444 T DK99913444 T DK 99913444T DK 99913444 T DK99913444 T DK 99913444T DK 1068328 T3 DK1068328 T3 DK 1068328T3
Authority
DK
Denmark
Prior art keywords
diagnosis
treatment
staphylococcal infections
same
staphylococcal
Prior art date
Application number
DK99913444T
Other languages
Danish (da)
English (en)
Inventor
James Peter Burnie
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Application granted granted Critical
Publication of DK1068328T3 publication Critical patent/DK1068328T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK99913444T 1998-03-31 1999-03-25 Behandling og diagnose af stafylokokinfektioner DK1068328T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806762.2A GB9806762D0 (en) 1998-03-31 1998-03-31 Treatment and diagnosis of staphylococcal infections

Publications (1)

Publication Number Publication Date
DK1068328T3 true DK1068328T3 (da) 2005-12-12

Family

ID=10829514

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913444T DK1068328T3 (da) 1998-03-31 1999-03-25 Behandling og diagnose af stafylokokinfektioner

Country Status (12)

Country Link
US (1) US6627730B1 (de)
EP (1) EP1068328B1 (de)
JP (1) JP4460156B2 (de)
AT (1) ATE310088T1 (de)
AU (1) AU752794B2 (de)
CA (1) CA2321960A1 (de)
DE (1) DE69928384T2 (de)
DK (1) DK1068328T3 (de)
ES (1) ES2248992T3 (de)
GB (1) GB9806762D0 (de)
NZ (1) NZ506196A (de)
WO (1) WO1999050418A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
EP1412379B1 (de) 2001-08-02 2012-01-25 The University Of Sheffield Impfstoff
GB0127983D0 (en) 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
ES2730275T3 (es) 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
US20080241127A1 (en) * 2006-12-29 2008-10-02 Dyax Corp. Methods of Making Passive Immunotherapies
WO2010129779A1 (en) * 2009-05-07 2010-11-11 Biomerieux, Inc. Methods for antimicrobial resistance determination
US9556281B2 (en) 2011-08-15 2017-01-31 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein A
US10918747B2 (en) 2015-07-30 2021-02-16 Vital Vio, Inc. Disinfecting lighting device
US10357582B1 (en) 2015-07-30 2019-07-23 Vital Vio, Inc. Disinfecting lighting device
CA2993825C (en) 2015-07-30 2020-08-25 Vital Vio, Inc. Single diode disinfection
US20180185533A1 (en) 2016-12-29 2018-07-05 Vital Vio, Inc. Control systems for disinfecting light systems and methods of regulating operations of disinfecting light systems
US10835627B2 (en) 2017-12-01 2020-11-17 Vital Vio, Inc. Devices using flexible light emitting layer for creating disinfecting illuminated surface, and related method
US10309614B1 (en) 2017-12-05 2019-06-04 Vital Vivo, Inc. Light directing element
US10413626B1 (en) 2018-03-29 2019-09-17 Vital Vio, Inc. Multiple light emitter for inactivating microorganisms
US12194168B2 (en) 2018-12-19 2025-01-14 Vyv, Inc. Lighting and dissipation device
US11639897B2 (en) 2019-03-29 2023-05-02 Vyv, Inc. Contamination load sensing device
US11541135B2 (en) 2019-06-28 2023-01-03 Vyv, Inc. Multiple band visible light disinfection
WO2021030748A1 (en) 2019-08-15 2021-02-18 Vital Vio, Inc. Devices configured to disinfect interiors
US12528882B2 (en) 2019-09-13 2026-01-20 The University Of Chicago Methods and compositions for treating staphylococcal infections
US11878084B2 (en) 2019-09-20 2024-01-23 Vyv, Inc. Disinfecting light emitting subcomponent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737248B2 (en) * 1996-01-05 2004-05-18 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
ID21487A (id) * 1996-11-13 1999-06-17 Du Pont Metoda pembuatan 1,3 - propandiol dengan organisme rekombinan
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US6300094B1 (en) * 1997-12-18 2001-10-09 Smithkline Beecham Corporation Polynucleotides encoding a novel ABC transporter

Also Published As

Publication number Publication date
WO1999050418A1 (en) 1999-10-07
AU752794B2 (en) 2002-10-03
JP2002509724A (ja) 2002-04-02
DE69928384D1 (de) 2005-12-22
CA2321960A1 (en) 1999-10-07
AU3156699A (en) 1999-10-18
ATE310088T1 (de) 2005-12-15
EP1068328A1 (de) 2001-01-17
DE69928384T2 (de) 2006-06-01
ES2248992T3 (es) 2006-03-16
US6627730B1 (en) 2003-09-30
NZ506196A (en) 2002-02-01
GB9806762D0 (en) 1998-05-27
JP4460156B2 (ja) 2010-05-12
EP1068328B1 (de) 2005-11-16

Similar Documents

Publication Publication Date Title
GB9806762D0 (en) Treatment and diagnosis of staphylococcal infections
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
DE60131138D1 (de) Antibakterielle mittel
ATE355293T1 (de) Substituierte 7-aza-(2.2.1)bicycloheptane für die behandlung von krankheiten
DE69939820D1 (de) Internalisierende erbb2 antikörper
GB0008305D0 (en) Treatment of fungal infections
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
PT827512E (pt) Anticorpo especifico para staphylococcus aureus e sua utilizacao
GB2377295A (en) Conversational dealing system
EP1262556A3 (de) Antimikrobielle Peptide und Verfahren zu ihrer Identifizierung und Verwendung
TR200002114T2 (tr) N-Aril-Triyazolin(eti)yon ve N-Arilsülfonil-Amino-(Tiyo)karbonil-Triyazolin(eti)yon Tabanlı seçilmiş herbisitler
BR9916507A (pt) Proteìnas
BR0015872A (pt) Agentes antitrombóticos
MXPA01010437A (es) Complejo epitope fab del anticuerpo monoclonal 2f5 de neutralizacion cruzada de hiv-1.
PT1095059E (pt) Proteina inibidora de quimiotaxia de estafilococos (chips) e sua utilizacao
EP0653215A4 (de) Kühler für blutplasmakühlbeutel.
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
EP0617889A3 (de) Herbizide Zusammensetzung.
NO20005548D0 (no) Mykobakterieinhibitorer
FR2793385B1 (fr) Agrafe de palissage autocassante
ATE285796T1 (de) Präparation von hypericin gebunden an poly-n- vinylamiden